The ATRIA and Modified-ATRIA Scores in Evaluating the Risk of No-Reflow in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention

被引:7
作者
Abacioglu, Ozge Ozcan [1 ]
Yildirim, Arafat [1 ]
Koyunsever, Nermin Yildiz [1 ]
Kilic, Salih [1 ]
机构
[1] Hlth Sci Univ, Adana Res & Training Hosp, Dept Cardiol, Dr Mithat Ozsan Bulvari Kisla Mah 4522,Sok 1, Adana, Turkey
关键词
ATRIA; no-reflow; ST-elevation myocardial infarction; ELEVATION MYOCARDIAL-INFARCTION; LYMPHOCYTE RATIO; ASSOCIATION; UNDERWENT; ADMISSION; PLATELET; MONOCYTE; PREDICT; UTILITY;
D O I
10.1177/00033197211026420
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The no-reflow (NR) phenomenon is frequently encountered in acute coronary syndrome. We evaluated the association between anticoagulation and risk factors in atrial fibrillation (ATRIA) and modified ATRIA risk scores and NR in ST-elevation myocardial infarction (STEMI). Consecutive patients (n = 551) who underwent primary percutaneous coronary intervention between December 2019 and June 2020 due to STEMI were included. The mean age of the patients was 60.5 +/- 10.8 years (n = 369, 67% male). The ATRIA and modified anticoagulation and risk factors in atrial fibrillation-hyperlipidemia, smoking, male (m-ATRIA-HS) scores were calculated. The NR group had higher frequency of diabetes mellitus (DM), serum creatine kinase-MB (CK-MB) levels, and corrected thrombolysis in myocardial infarction frame count (cTFC) (P = .002, P = .006, and P < .001, respectively). In regression analysis, ATRIA, m-ATRIA-HS, thrombus grade, and cTFC were independent predictors of NR. Age, higher CK-MB, and neutrophil-to-lymphocyte ratio and DM were the other predictors for NR. Pairwise comparison of receiver operating characteristics curve analysis showed that the m-ATRIA-HS (>2, area under curve [AUC]: 0.715) has better performance than ATRIA score (>1, AUC: 0.656), with a P < .022 and z statistics 2.279. In conclusion, ATRIA, especially the m-ATRIA-HS, can be used to evaluate NR risk in STEMI.
引用
收藏
页码:79 / 84
页数:6
相关论文
共 45 条
[1]   The utility of the TIMI risk index on admission for predicting angiographic no-reflow after primary percutaneous coronary intervention in patients with STEMI [J].
Acet, Halit ;
Ertas, Faruk ;
Akil, Mehmet Ata ;
Bilik, Mehmet Zihni ;
Aydin, Mesut ;
Polat, Nihat ;
Yildiz, Abdulkadir ;
Yuksel, Murat ;
Ciftci, Leyla ;
Ozaydogdu, Necdet ;
Ozbek, Mehmet ;
Alan, Sait ;
Toprak, Nizamettin .
TURKISH JOURNAL OF MEDICAL SCIENCES, 2016, 46 (03) :604-613
[2]  
Adjedj J, 2018, PRIMARY ANGIOPLASTY, P223
[3]   Association between SYNTAX II score and electrocardiographic evidence of no-reflow in patients with ST-segment elevation myocardial infraction [J].
Askin, Lutfu ;
Akturk, Erdal .
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2018, 46 (06) :455-463
[4]  
Avci E, 2018, EUR REV MED PHARMACO, V22, P4987, DOI 10.26355/eurrev_201808_15639
[5]  
Bahrehmand M, 2015, J Med Life, V8, P59
[6]   The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction [J].
Balta, Sevket ;
Celik, Turgay ;
Ozturk, Cengiz ;
Kaya, M. Gungor ;
Aparci, Mustafa ;
Yildirim, A. Osman ;
Demir, Mustafa ;
Kilic, Selim ;
Aydin, Ibrahim ;
Iyisoy, Atila .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (08) :1542-1547
[7]   The CHADS-VASc score is a predictor of no-reflow in patients with non-ST-segment elevation myocardial infarction [J].
Barman, Hasan Ali ;
Kahyaoglu, Serdar ;
Durmaz, Eser ;
Atici, Adem ;
Gulsen, Kamil ;
Tugrul, Sevil ;
Isleyen, Hasan Burak ;
Yildirim, Mehmet Rifat ;
Gungor, Baris ;
Okuyan, Ertugrul ;
Sahin, Irfan .
CORONARY ARTERY DISEASE, 2020, 31 (01) :7-12
[8]   Prediction of no-reflow and major adverse cardiovascular events with a new scoring system in STEMI patients [J].
Bayramoglu, Adil ;
Tasolar, Hakan ;
Kaya, Ahmet ;
Tanboga, Ibrahim Halil ;
Yaman, Mehmet ;
Bektas, Osman ;
Gunaydin, Zeki Yuksel ;
Oduncu, Vecih .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2018, 31 (02) :144-149
[9]   Treating and Preventing No Reflow in the Cardiac Catheterization Laboratory [J].
Berg, Ryan ;
Buhari, Cyrus .
CURRENT CARDIOLOGY REVIEWS, 2012, 8 (03) :209-214
[10]   The no-reflow phenomenon: State of the art [J].
Bouleti, Claire ;
Mewton, Nathan ;
Germain, Stephane .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2015, 108 (12) :661-674